The Dynamic Media, Sera and Reagent Market in Biotechnology

Report Code: BIO014C

Publish Date: Sep 2000

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The U.S. cell culture media market has been growing at a surprisingly fast pace since the last edition of this report, and some of the media suppliers are enjoying a growth rate higher than the overall rate. The U.S. market for cell culture media was estimated to be about $169.5 million in 1999. This is projected to grow to $190.2 million in 2000, and to reach $343.7 million in the year 2005. The estimated average annual growth rate is projected to be about 12.5%.
  • The sera portion of the U.S. market was an estimated $173.9 million in 1999. It should grow to $183.2 million by 2000, and $238.4 million by 2005. The average growth rate is expected to be 5.4% per year throughout this period.
  • The U.S. market for reagents used in cell culture was an estimated $151.7 million in 1999. This should grow to $170.4 million by 2000, and to $315.1 million by 2005. The average growth rate through this period is projected to be 13.0% per year.


INTRODUCTION

STUDY GOAL AND OBJECTIVES

The main goal of this study is to analyze the markets for sera, media, and reagents in the biotechnology industry. It is fair to say that sera, media, and reagents are fundamental to molecular and cellular biology and immunology research, and, as a result, they are vital to the health of the biotech industry. A timely analysis of the state of the industry is in order.

 

REASONS FOR DOING THE STUDY

The main reason for this study is to profile an important area of biotechnology that has been undergoing tremendous growth in the last few years. There have been a lot of changes since Dynamic Media, Sera and Reagents Market in Biotechnology [ Communication Co., September 1995] was published, which focused on the state of the media, sera, and reagent market. Approval times for new drugs have been reduced, there are more drugs in clinical trials and production stage, and research towards new drugs is escalating. All of these factors affect the demand for cell culture media, sera, and reagents. In addition, nascent fields, such as tissue engineering, cellular therapy, and gene therapy, are sure to add to the level of demand for media, sera, and reagents over the next several years.

It is very clear that in the recent past the cell culture media market has undergone changes that have injected this market with dramatic growth, and the picture looks very positive for the foreseeable future. There are new products in the media market, the emphasis has shifted from serum-supplemented media to reduced serum and serum-free media, and there is emergence of media that is animal-component free. It seems like the twentieth century, which saw the birth of mammalian cell culture and its growth and dependence on supplementation of cell culture media with animal serum, is giving way to the twenty-first century, which will see the maturation of mammalian cell culture in completely chemically defined media with different media being designed for the different goals of cell and tissue culture.

CONTRIBUTION OF THE STUDY AND ITS TARGET AUDIENCE

This study will shed light on the following areas:

  • Range of products available for cell culture;
  • Structure and current market size of the markets for media, sera, and reagents, with forecasts through 2005;
  • Changes in media, sera, and reagent usage patterns and trends;
  • Government and regulatory controls on cell culture media products;
  • The major players in the industry;
  • Range of emerging new products and technologies;
  • The international cell culture media markets and how they are changing; and
  • Future directions.

This study provides and technical information of a timely nature, and it will prove valuable to a variety of readers, including industry executives, managers and planners, industry analysts, and investors.

SCOPE AND FORMAT

This study defines and provides background information on products that fall under the classification of cell culture media, sera, and reagents. It takes a close look at the size of the market for these products and analyzes its growth trend. Possible new markets are also discussed.

METHODOLOGY

At the outset, an exhaustive literature search was done. The literature consulted included technical newsletters and journals, and trade papers in both print and online formats. Government sources as well as other online databases were also searched.

The information gained from the literature search provided the background for acquiring more detailed and specific information relating to the cell culture media markets. A number of different scenarios were considered, and these were substantiated with more relevant information gleaned from various sources, including interviews with marketing managers and media suppliers. The market trends were analyzed and predictions made based on several assumptions that are enumerated alongside of the forecasts.

Predictions were based on industry consensus, the funding levels, and shifts in priorities by both consumers and suppliers. Estimates were also based on demographics and rates of consumption. Every effort was made to make the estimates and projections as reliable as possible and to be within a narrow margin of error. However, these predictions are by their very nature speculative. They are a composite of opinions and assessments by interviewees, the author, other analysts and secondary sources. The relative importance of selected factors could change at any time with new technologies and new products, and thus change the direction of the market projections.

To determine the industry consensus, a questionnaire was designed and drafted.  Key executives from the companies involved in media manufacture and supply were interviewed and their answers to the questions in the questionnaire noted.  Attempts were made to include as many media manufacturers and suppliers as possible, but quite a few of those contacted declined to comment, citing the proprietary nature of the information.  Some of the questions from the questionnaire used in the interviews are highlighted below.

  • Who are your customers — universities, biotech companies, contract research organizations (CROs), or hospitals and clinics; or a combination of one or more?
  • What is the size of the market for cell culture media, sera, and reagents, respectively?
  • What is the ratio of research versus industry in terms of the market size for cell culture media, sera, and reagents?
  • What percentage do hospitals and contract research organizations make up?
  • At what annual rate is the market growing for cell culture media, sera, and cell culture reagents respectively?  Is this rate unexpected?
  • Who are the industry leaders among the cell culture media, sera, and cell culture reagent manufacturers and suppliers?  What position is your company in, and is it likely to change?
  • What is the total consumption in the United States and worldwide for cell culture medium and sera, and cell culture reagents, respectively?
  • Is the market for cell culture media growing faster than that for sera?
  • Is there an increase in the size of the market for custom media and serum-free media formulations?
  • What are the current prices for fetal bovine and other types of sera, and are they likely to change?
  • What are the sources of the sera that you supply?  Are they all domestic, or are there imported sera as well?  If you supply imported sera, which countries are they imported from?
  • Do you think that the emergence of CROs has resulted in an increase or decrease in the consumption of cell culture media, sera, and reagents?
  • What do you see as the future trends in this field?
  • What do you think will be the impact of the $2 billion increase in the budget of the National Institutes of Health (NIH) for the year 2000-2001 on the cell culture media and sera market?
  • Is there a likelihood of pharmaceutical companies increasing their research and development budgets?

INFORMATION SOURCES

A broad range of information sources was consulted in preparing this study. The sources consulted included newsletters, company literature, product literature, a host of technical articles, journals, indexes, and abstracts, as well as trade magazines, books, and reference guides. Also, a number of different computer searches were carried out. Exhaustive investigations of databases by key terminology were performed.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: The Dynamic Media, Sera and Reagent Market in Biotechnology95Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY4Free
Chapter- 3: MEDIA USE IN BIOTECHNOLOGY17Free
Chapter- 4: PRODUCT ANALYSIS15Free
Chapter- 5: COST ANALYSIS OF MEDIA, SERA, AND REAGENTS3Free
Chapter- 6: REGULATORY ISSUES ASSOCIATED WITH MEDIA AND SERA5Free
Chapter- 7: MARKET ANALYSIS13Free
Chapter- 8: INDUSTRY STRUCTURE23Free
Chapter- 9: INTERNATIONAL ANALYSIS8Free
Chapter- 10: FUTURE DIRECTIONS3Free

Related Reports

Recent Reports

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - Partha Sarathi Das | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the  chemical industry.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
The Dynamic Media, Sera and Reagent Market in Biotechnology
Customize Report